Warning to women amid shortages of some HRT products
Health officials have issued a warning to women regarding shortages of specific Hormone Replacement Therapy (HRT) products. Patients are advised to consult their GPs or pharmacists for safe alternatives rather than attempting to self-medicate.
Why it matters
Supply chain disruptions for essential medications can cause significant health risks and anxiety for patients managing menopause symptoms.
Image source, Getty Images Image caption, Women have been urged to seek advice from their GP or pharmacy if they find their usual HRT has been affected by supply shortages
Women have been warned against self-medicating to manage menopause symptoms amid a shortage of some Hormone Replacement Therapy (HRT) medications.
Pharmacist Paul Irvine said he understood that women were "concerned" but urged them to speak to their GP or local chemist who could advise them about alternatives.
The warning follows official confirmation from the Department of Health (DoH) that supplies of two major HRT patch brands have been disrupted.
The affected products include Estradot transdermal and FemSeven Conti, both of which are currently facing manufacturing or distribution delays.
Image caption, Paul Irvine said it was important that women contact their GP or pharmacist for advice
Also covering this story
One other newsroom covered this event. We read that version too.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in